Contents

Current Pharmaceutical Design, Volume 15 - Number 16

Editorial [Hot Topic: Inflammation as Target for Pharmaceutical Intervention in Cancer (Executive Editors: R.M. Schiffelers and K.E. de Visser)]

, 15(16): 1822 - 1824

Raymond M. Schiffelers and Karin E. de Visser


DOI: 10.2174/138161209788453257




Targeted Delivery of Anti-Inflammatory Agents to Tumors

, 15(16): 1825 - 1843

Maria Coimbra, Sylvia A. Kuijpers, Sebastiaan P. van Seters, Gert Storm and Raymond M. Schiffelers


DOI: 10.2174/138161209788453220




Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance

, 15(16): 1844 - 1853

Karin E. de Visser and Jos Jonkers


DOI: 10.2174/138161209788453239




III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment

, 15(16): 1854 - 1867

Mitsuko Furuya, Yoshikazu Yonemitsu and Ichiro Aoki


DOI: 10.2174/138161209788453275




Mast Cells as Target in Cancer Therapy

, 15(16): 1868 - 1878

Tom Groot Kormelink, Abulikemu Abudukelimu and Frank A. Redegeld


DOI: 10.2174/138161209788453284




Regulatory T Cells: Major Players in the Tumor Microenvironment

, 15(16): 1879 - 1892

Marc Beyer and Joachim L. Schultze


DOI: 10.2174/138161209788453211




Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm

, 15(16): 1893 - 1917

Peng Zhan and Xinyong Liu


DOI: 10.2174/138161209788453266




Scientific and Clinical Challenges in Sepsis

, 15(16): 1918 - 1935

Luis Ulloa, Michael Brunner, Laura Ramos and Edwin A. Deitch


DOI: 10.2174/138161209788453248




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science